Sihuan Pharmaceutical Holdings Group (0460) Price & Analysis

Compare

1 Followers

0460 Stock Chart & Stats

HK$1.25

HK$0.00(0.00%)

At close: Jan 09 4:00 PM EST

HK$1.25

HK$0.00(0.00%)

Day’s Range― - ―

52-Week RangeHK$0.53 - HK$1.92

Previous CloseN/A

Volume8.01M

Average Volume (3M)37.54M

Market Cap

HK$11.76B

Enterprise ValueHK$7.73B

Total Cash (Recent Filing)HK$3.60B

Total Debt (Recent Filing)HK$1.03B

Price to Earnings (P/E)―

Beta1.06

Next Earnings

Mar 31, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.83%

Share Statistics

EPS (TTM)0.01

Shares Outstanding9,329,999,000

10 Day Avg. Volume24,963,024

30 Day Avg. Volume37,542,935

Financial Highlights & Ratios

PEG Ratio-0.09

Price to Book (P/B)1.31

Price to Sales (P/S)3.02

P/FCF Ratio99.87

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Sihuan Pharmaceutical Holdings Group News

Sihuan Pharma Buys 9 Million Shares for Award Scheme as Dual-Drive Strategy Advances

The latest update is out from Sihuan Pharmaceutical Holdings Group ( ($HK:0460) ). Sihuan Pharmaceutical Holdings Group has...

11h ago

Sihuan Pharmaceutical’s Anjiuwei Secures Spot in 2025 NRDL, Boosting Market Prospects

An update from Sihuan Pharmaceutical Holdings Group ( ($HK:0460) ) is now available. Sihuan Pharmaceutical Holdings Group announced...

11d ago

Sihuan Pharmaceutical’s Innovative Drug Xuanyuening Gains NRDL Inclusion

An update from Sihuan Pharmaceutical Holdings Group ( ($HK:0460) ) is now available. Sihuan Pharmaceutical Holdings Group Ltd....

11d ago

Sihuan Pharmaceutical’s Xuanzhu Biopharma Plans H Share Full Circulation

The latest announcement is out from Sihuan Pharmaceutical Holdings Group ( ($HK:0460) ). Sihuan Pharmaceutical Holdings Group Ltd....

1M ago

Sihuan Pharmaceutical Partners with Abalone Bio for Innovative Obesity Therapy

Sihuan Pharmaceutical Holdings Group ( ($HK:0460) ) has issued an update. Sihuan Pharmaceutical Holdings Group Ltd. has signed...

2M ago

Sihuan Pharmaceutical’s NG-350A Receives FDA Fast Track Designation

The latest update is out from Sihuan Pharmaceutical Holdings Group ( ($HK:0460) ). Sihuan Pharmaceutical Holdings Group Ltd....

2M ago

Sihuan Pharmaceutical Announces Strategic Share Repurchase Amidst Strong Business Growth

Sihuan Pharmaceutical Holdings Group ( ($HK:0460) ) just unveiled an update. Sihuan Pharmaceutical Holdings Group Ltd. announced a...

2M ago

Sihuan Pharmaceutical Announces Strategic Share Repurchase Amidst Business Growth

Sihuan Pharmaceutical Holdings Group ( ($HK:0460) ) has provided an announcement. Sihuan Pharmaceutical Holdings Group Ltd. announced a...

2M ago

Sihuan Pharmaceutical Strengthens Market Position with Share Purchase

An update from Sihuan Pharmaceutical Holdings Group ( ($HK:0460) ) is now available. Sihuan Pharmaceutical Holdings Group Ltd....

2M ago

Sihuan Pharmaceutical Successfully Lists Xuanzhu Biopharm on Hong Kong Stock Exchange

Sihuan Pharmaceutical Holdings Group ( ($HK:0460) ) just unveiled an announcement. Sihuan Pharmaceutical Holdings Group Ltd. has successfully...

2M ago

0460 FAQ

What was Sihuan Pharmaceutical Holdings Group Ltd.’s price range in the past 12 months?

Sihuan Pharmaceutical Holdings Group Ltd. lowest stock price was HK$0.53 and its highest was HK$1.92 in the past 12 months.

What is Sihuan Pharmaceutical Holdings Group Ltd.’s market cap?

Sihuan Pharmaceutical Holdings Group Ltd.’s market cap is HK$11.76B.

When is Sihuan Pharmaceutical Holdings Group Ltd.’s upcoming earnings report date?

Sihuan Pharmaceutical Holdings Group Ltd.’s upcoming earnings report date is Mar 31, 2026 which is in 103 days.

How were Sihuan Pharmaceutical Holdings Group Ltd.’s earnings last quarter?

Sihuan Pharmaceutical Holdings Group Ltd. released its earnings results on Aug 29, 2025. The company reported HK$0.012 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.012.

Is Sihuan Pharmaceutical Holdings Group Ltd. overvalued?

According to Wall Street analysts Sihuan Pharmaceutical Holdings Group Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Sihuan Pharmaceutical Holdings Group Ltd. pay dividends?

Sihuan Pharmaceutical Holdings Group Ltd. pays a Annually dividend of HK$0.011 which represents an annual dividend yield of 0.83%. See more information on Sihuan Pharmaceutical Holdings Group Ltd. dividends here

What is Sihuan Pharmaceutical Holdings Group Ltd.’s EPS estimate?

Sihuan Pharmaceutical Holdings Group Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Sihuan Pharmaceutical Holdings Group Ltd. have?

Sihuan Pharmaceutical Holdings Group Ltd. has 9,329,999,000 shares outstanding.

What happened to Sihuan Pharmaceutical Holdings Group Ltd.’s price movement after its last earnings report?

Sihuan Pharmaceutical Holdings Group Ltd. reported an EPS of HK$0.012 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.329%.

Which hedge fund is a major shareholder of Sihuan Pharmaceutical Holdings Group Ltd.?

Currently, no hedge funds are holding shares in HK:0460

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Sihuan Pharmaceutical Holdings Group Stock Smart Score

Outperform

Technicals

Fundamentals

Return on Equity

-1.87%

Trailing 12-Months

Asset Growth

-6.55%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.